Detalhe da pesquisa
1.
A Phase Ib Trial of Personalized Neoantigen Therapy Plus Anti-PD-1 in Patients with Advanced Melanoma, Non-small Cell Lung Cancer, or Bladder Cancer.
Cell
; 183(2): 347-362.e24, 2020 10 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33064988
2.
A Cancer Cell Program Promotes T Cell Exclusion and Resistance to Checkpoint Blockade.
Cell
; 175(4): 984-997.e24, 2018 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30388455
3.
Landscape of helper and regulatory antitumour CD4+ T cells in melanoma.
Nature
; 605(7910): 532-538, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35508657
4.
Phenotype, specificity and avidity of antitumour CD8+ T cells in melanoma.
Nature
; 596(7870): 119-125, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34290406
5.
Loss of PTEN Is Associated with Resistance to Anti-PD-1 Checkpoint Blockade Therapy in Metastatic Uterine Leiomyosarcoma.
Immunity
; 46(2): 197-204, 2017 02 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-28228279
6.
Neoantigen vaccine generates intratumoral T cell responses in phase Ib glioblastoma trial.
Nature
; 565(7738): 234-239, 2019 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30568305
7.
INDUCE-2: A Phase I/II, open-label, two-part study of feladilimab in combination with tremelimumab in patients with advanced solid tumors.
Cancer Immunol Immunother
; 73(3): 44, 2024 Feb 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-38349570
8.
Ziv-aflibercept plus pembrolizumab in patients with advanced melanoma resistant to anti-PD-1 treatment.
Cancer Immunol Immunother
; 73(1): 17, 2024 Jan 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-38236249
9.
Corrigendum: An immunogenic personal neoantigen vaccine for patients with melanoma.
Nature
; 555(7696): 402, 2018 03 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-29542692
10.
Precision cancer medicine: Concepts, current practice, and future developments.
J Intern Med
; 294(4): 455-481, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37641393
11.
A phase I/II study of MCS110 with BRAF/MEK inhibition in patients with melanoma after progression on BRAF/MEK inhibition.
Invest New Drugs
; 41(3): 365-370, 2023 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-37097370
12.
A phase I/II study of LY3022855 with BRAF/MEK inhibition in patients with Melanoma.
Invest New Drugs
; 41(4): 551-555, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37247116
13.
An immunogenic personal neoantigen vaccine for patients with melanoma.
Nature
; 547(7662): 217-221, 2017 07 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-28678778
14.
Optimized Liquid and Gas Phase Fractionation Increases HLA-Peptidome Coverage for Primary Cell and Tissue Samples.
Mol Cell Proteomics
; 20: 100133, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34391888
15.
Efficacy and safety of pembrolizumab for patients with previously treated advanced vulvar squamous cell carcinoma: Results from the phase 2 KEYNOTE-158 study.
Gynecol Oncol
; 166(2): 211-218, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35361487
16.
A multi-center study on safety and efficacy of immune checkpoint inhibitors in cancer patients with kidney transplant.
Kidney Int
; 100(1): 196-205, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33359528
17.
Cytokine changes during immune-related adverse events and corticosteroid treatment in melanoma patients receiving immune checkpoint inhibitors.
Cancer Immunol Immunother
; 70(8): 2209-2221, 2021 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-33481042
18.
NCCN Guidelines® Insights: Melanoma: Cutaneous, Version 2.2021.
J Natl Compr Canc Netw
; 19(4): 364-376, 2021 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33845460
19.
Vitamin D intake is associated with decreased risk of immune checkpoint inhibitor-induced colitis.
Cancer
; 126(16): 3758-3767, 2020 08 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-32567084
20.
Pembrolizumab for the treatment of programmed death-ligand 1-positive advanced carcinoid or pancreatic neuroendocrine tumors: Results from the KEYNOTE-028 study.
Cancer
; 126(13): 3021-3030, 2020 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32320048